Globus Medical, Inc. (GMED) vs Tempus AI, Inc. (TEM)

A side-by-side comparison of Globus Medical, Inc. and Tempus AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnGMED vs TEM

growth of $100 · dividends reinvested · last 2y
GMED +28.2% (+13.2%/yr)TEM +75.6% (+32.5%/yr)TEM compounded faster over this window
50100150200250Start $10020252026$128$176
GMED TEM

GMED vs TEM: by the numbers

  • TEM is the larger company ($11.22B vs $11.19B market cap).
  • GMED is profitable (17.03% net margin) while TEM runs a net loss (-17.77%).
  • TEM grew revenue faster over the past five years (38.24% vs 27.65% CAGR).

Metrics side by side

Valuation

MetricGMEDTEM
P/E ratio21.33N/A
Forward P/E16.66N/A
P/S ratio3.659.00
P/B ratio2.4028.98
EV / EBITDA11.86N/A
FCF yield6.54%N/A

Profitability

MetricGMEDTEM
Gross margin68.55%63.98%
Operating margin20.75%-19.76%
Net margin17.03%-17.77%
ROE11.23%-57.18%
ROIC10.49%-14.34%

Growth (annualized)

MetricGMEDTEM
Revenue CAGR (5Y)27.65%38.24%
EPS CAGR (5Y)30.79%N/A
FCF CAGR (5Y)29.93%N/A
Total return CAGR (5Y)0.33%N/A

Frequently asked

Which has grown faster, GMED or TEM?
Over the past five years, TEM grew revenue faster — GMED at a 27.65% CAGR versus TEM at 38.24%.
Is GMED or TEM more profitable?
GMED runs the higher net margin — GMED at 17.03% versus TEM at -17.77%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.